Bishop D K, Li W, Chan S Y, Ensley R D, Shelby J, Eichwald E J
Section of Thoracic Surgery, University of Michigan School of Medicine, Ann Arbor 48109.
Transplantation. 1994 Sep 15;58(5):576-84. doi: 10.1097/00007890-199409150-00009.
Initial treatment of heterotopic cardiac transplant recipients with anti-CD4 mAb promotes long-term (> 60 days) allograft survival. We have used modified limiting dilution analysis to quantitate donor alloantigen-reactive helper T lymphocytes (HTL) and CTL in mice bearing long-term cardiac allografts. Despite repopulation of lymphoid tissues with CD4+ T cells, donor alloantigen-reactive IL-2 producing and IL-4-producing HTL were rare or not detectable in lymphoid tissues or in the graft. While donor-reactive precursor CTL were present in lymphoid tissues, modified limiting dilution analysis revealed that stimulated ("antigen-conditioned") CTL were not detectable, and few CTL were present in the graft. In addition, antibodies reactive with donor alloantigens were not detectable in the sera of mice bearing long-term cardiac allografts. To determine whether additional in vivo stimulation with donor alloantigens would elicit an immune response, sponge allografts were implanted into mice bearing long-term cardiac allografts. Previous reports from this laboratory have demonstrated that T cell infiltration of sponge allografts is dependent upon antigen-driven cytokine production. While third-party sponge allografts were readily infiltrated by third-party-reactive HTL and CTL, sponge allografts of the same strain as the cardiac allograft were not infiltrated by T cells. However, donor strain sponge allografts induced an IgM (but not IgG) alloantibody response. These data indicate that IgM alloantibody could be induced in the absence of a cellular response to the sponge allograft. Kinetic studies revealed that a transient IgM (but not IgG) response was induced by the initial cardiac transplantation in the absence of CD4+ cells. These IgM alloantibodies disappeared by day 21 despite the persistence of the allograft. These observations indicate that transient depletion of CD4+ T cells induces allograft-specific T cell tolerance, but does not eliminate the ability to mount an allograft-specific IgM response. To our knowledge, this is the first report of a transient humoral response to alloantigens that occurs in the absence of CD4+ T cells, and can be reinduced in "tolerant" animals that fail to mount a cellular immune response. Potential mechanisms involved in the development and maintenance of anti-CD4 mAb-induced tolerance are discussed.
用抗CD4单克隆抗体对异位心脏移植受者进行初始治疗可促进长期(>60天)同种异体移植物存活。我们已使用改良的极限稀释分析法来定量携带长期心脏同种异体移植物的小鼠体内供体同种异体抗原反应性辅助性T淋巴细胞(HTL)和细胞毒性T淋巴细胞(CTL)。尽管淋巴组织中重新填充了CD4 + T细胞,但在淋巴组织或移植物中,供体同种异体抗原反应性产生白细胞介素-2和产生白细胞介素-4的HTL很少见或无法检测到。虽然供体反应性前体CTL存在于淋巴组织中,但改良的极限稀释分析显示,刺激后的(“抗原预处理的”)CTL无法检测到,且移植物中存在的CTL很少。此外,在携带长期心脏同种异体移植物的小鼠血清中未检测到与供体同种异体抗原反应的抗体。为了确定用供体同种异体抗原进行额外的体内刺激是否会引发免疫反应,将海绵同种异体移植物植入携带长期心脏同种异体移植物的小鼠体内。本实验室先前的报告表明,海绵同种异体移植物的T细胞浸润取决于抗原驱动的细胞因子产生。虽然第三方海绵同种异体移植物很容易被第三方反应性HTL和CTL浸润,但与心脏同种异体移植物相同品系的海绵同种异体移植物未被T细胞浸润。然而,供体品系海绵同种异体移植物诱导了IgM(而非IgG)同种异体抗体反应。这些数据表明,在对海绵同种异体移植物无细胞反应的情况下可诱导IgM同种异体抗体产生。动力学研究表明,在没有CD4 +细胞的情况下,初始心脏移植可诱导短暂的IgM(而非IgG)反应。尽管同种异体移植物持续存在,但这些IgM同种异体抗体在第21天时消失。这些观察结果表明,CD4 + T细胞的短暂耗竭可诱导同种异体移植物特异性T细胞耐受,但不会消除产生同种异体移植物特异性IgM反应的能力。据我们所知,这是首次报道在没有CD4 + T细胞的情况下发生的对同种异体抗原的短暂体液反应,并且可以在未能产生细胞免疫反应的“耐受”动物中再次诱导产生。本文讨论了抗CD4单克隆抗体诱导耐受的发生和维持所涉及的潜在机制。